By Sabela Ojea
Palisade Bio withdrew its Dec. 29 S-1 filing for a stock offering on Friday, and said it will seek stockholder approval for a potential reverse split. Shares of the biotechnology company surge 37% to 71 cents in after-hours trading.
Write to Sabela Ojea at [email protected]
Read the full article here
